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ABSTRACT 3 
Purpose: To determine target volume changes using volume and shape analysis for 4 
patients receiving radiotherapy following breast conservation surgery. To compare 5 
different methods of automatically identifying changes in target volume, position, size 6 
and shape during radiotherapy for use in adaptive radiotherapy.   7 
Methods and Materials: Eleven patients undergoing whole breast radiotherapy had 8 
fiducial markers sutured into the excision cavity at the time of surgery. Patients were 9 
imaged using CT (for planning and at the end of treatment) and during treatment 10 
using portal imaging. A marker volume (MV) was defined using the measured marker 11 
positions. Changes in both the individual marker positions and in the MV were 12 
identified manually and using six automated similarity indices. Comparison of the two 13 
types of analysis (manual and automated) was undertaken to establish whether the 14 
similarity indices can be used to automatically detect changes in target volumes. 15 
Results:  Manual analysis showed that 3 patients had significant marker volume 16 
reduction. This analysis also showed significant changes between planning CT and 17 
start of treatment for 9 patients, including single and multiple marker movement, 18 
deformation (shape change) and rotation. Four of the six similarity indices were 19 
shown to be sensitive to the observed changes.  20 
Conclusions:  Significant changes in size, shape and position occur to the fiducial 21 
marker defined volume. Four similarity indices can be used to identify these changes 22 
and a protocol for their use in adaptive radiotherapy is suggested. 23 
 24 
 25 
 3 
1. INTRODUCTION 1 
Radiotherapy of the breast following breast conservation surgery is adjuvant treatment 2 
as the gross tumour volume has been excised leaving possible microscopic disease. 3 
Standard breast radiotherapy treats the whole breast, but the region with the highest 4 
risk of tumour recurrence is proximal to the excision cavity and this may be treated 5 
with a higher dose of radiation. The excision cavity may be localised using imaging 6 
techniques to visualise seroma (1,2), changes in tissue architecture (3,4) or fiducial 7 
markers implanted into the breast at the time of surgery (5). The commonest method 8 
uses a combination of fiducial markers (typically surgical clips) and soft tissue 9 
changes imaged using computed tomography (CT) to localise the excision cavity and 10 
margins to encompass possible sub-clinical spread of disease are added to create the 11 
clinical target volume (CTV). Using fiducial markers, the Centre of Mass (CoM) of 12 
the markers at the time of treatment can be compared to the CoM at the time of 13 
planning to calculate daily shifts in the position of the excision cavity (6,7).  In 14 
addition, changes in marker positions may arise due to deformation or volume change 15 
of the excision cavity (3) and fiducial marker migration (8,9) which will lead to 16 
changes in the size, shape and measured CoM of the measured volume.  17 
 18 
Deformation may result in underdosing of the CTV or overdosing of healthy adjacent 19 
tissues. Marker migration will change the shape of the measured volume and its CoM, 20 
consequently these may differ from the shape and CoM of the excision cavity as 21 
defined at the initial CT planning scan. Measurement and characterisation of changes 22 
in marker positions during treatment may help to: 23 
• identify time trends in changes of the excision cavity, 24 
• characterise deformation and 25 
 4 
• identify marker migration. 1 
Using this information, strategies may be developed so that a response to changes in 2 
the excision cavity may be made and the treatment tailored to the individual patient. 3 
 4 
The aims of this study were: 5 
1. To manually analyse target volume, shape and position with time, based on 6 
implanted fiducial markers imaged using projection x-rays to determine what 7 
changes occur. 8 
2. To investigate automated methods of comparing target volumes and positions 9 
using similarity indices to automatically detect changes in volume position, 10 
shape and orientation. 11 
3. To recommend an IGRT protocol for breast radiotherapy incorporating the use 12 
of similarity indices. 13 
 14 
2 MATERIALS AND METHODS 15 
The measured positions of implanted fiducial markers were used to define the marker 16 
volume (MV) which acts as a surrogate for the excision cavity which cannot be 17 
visualised using portal imaging (PI).  This was based on the envelope of the markers 18 
to obtain the maximum coverage of the target volume; illustrated in figure 1. We 19 
evaluated changes to the MV. Four methods (resulting in six possible similarity  20 
indices) were used to compare the  MV defined using CT at the time of planning 21 
(volume A) with that defined during treatment, imaged using PI (volume B). The first 22 
method uses the positions of the fiducial markers and the other 3 use the MV. The 23 
methods used were:  24 
 5 
1. Analysis of the second order moments of the positions of markers in A and B: 1 
in the three spatial dimensions (first order moment gives the CoM and has 2 
been studied by Coles et al. (6)). 3 
2. Volume analysis, including the measured volume of A and B and a volume 4 
index which gives the fractional change in the volume of the MV between 5 
planning and treatment images. 6 
3. The Jaccard Index (JI) which describes the volume overlap of A and B. 7 
4. The Minkowski Index (MI) which is sensitive to changes in volume shape 8 
only. 9 
If the CoMs of A and B are shifted to a common origin the analysis will be 10 
independent of any translation between the two volumes. For methods 1(second order 11 
moments), 2 (volume analysis) and 4 (MI) a CoM shift was applied prior to the 12 
analysis. For method 3 (JI), the analysis was performed before (JI1) and after (JI2) 13 
CoM shift. 14 
 15 
2.1 Patient study 16 
At The Royal Marsden Hospital, 11 patients gave informed consent to be entered into 17 
the National Cancer Research Network multi-centre GOLDSEED feasibility study 18 
evaluating the use of implanted fiducial markers for IGRT in patients with early breast 19 
cancer (5). Following wide local excision of the primary tumour, gold fiducial 20 
markers were sutured around the excision cavity following a strict surgical procedure. 21 
The markers were gold rings, 3mm in diameter, with a 1mm central hole and 1mm 22 
thickness. The intended number of markers was 6 but this was less in some patients 23 
due to re-excision or surgeon preference, therefore of the 11 patients recruited, 7 had 24 
 6 
6 markers inserted, 4 had 5 markers inserted and one patient had 4 markers sutured 1 
into the cavity.  2 
 3 
All patients were CT scanned prior to treatment (CT1) and in the last week, or just 4 
after, the end of their treatment (CT2). The CT axial slice separation was 1.25mm.  5 
The CT images were exported to the Pinnacle Treatment planning system (Phillips 6 
Medical Systems, Milpitas, CA, USA). The marker positions relative to the treatment 7 
isocentre were identified by manually locating the centre of each of the markers on 8 
the treatment planning system. The median time between surgery and CT1 was 88 9 
days (range 30 – 169 days). Three of the patients received Chemotherapy, the time 10 
between surgery and CT1 for these patients was 155, 157 and 169 days.  Ten patients 11 
received hormonal therapy.   12 
 13 
The patients were treated under 3 fractionation regimens. These were the current 14 
international standard of 50Gy in 25 fractions, and two regimes from randomised 15 
controlled trials - 30Gy in 5 fractions and 40Gy in 15 fractions. No changes were 16 
made to their treatment based upon the fiducial markers.  17 
 18 
Portal images were acquired on the first treatment day and between 4 and 13 19 
subsequent treatment days. The median time between CT1 and the first day of 20 
treatment was 13 days. The images were acquired using an Elekta iViewGT EPID.  21 
Two orthogonal portal images were acquired to locate the markers in 3D. One image 22 
was acquired using the anterior tangential treatment beam. The second image was 23 
acquired with the gantry placed orthogonal to this beam (using 1MU).  Examples of 24 
 7 
orthogonal portal images of the implanted fiducial markers are shown in figure 2. 1 
Each marker position was calculated using triangulation with in-house software. 2 
 3 
Observer errors associated with the measurements were evaluated by 3 physicists 4 
locating the markers 3 times each with both CT and PI and using statistical methods 5 
outlined by Bland and Altman (10).   Changes in the MVs throughout treatment were 6 
made by analysing the patient data manually. These observed changes were used as 7 
the gold standard with which we compared the changes identified using the similarity 8 
indices.  9 
 10 
Translation was measured using the CoM shifts. A significant translation is defined as 11 
a shift greater than 5mm (the local set up tolerance).  The median magnitude of 12 
rotation was 5° hence this was used as threshold to identify MVs with large rotation. 13 
Significant volume reduction is defined as a volume reduction outside the 95% C.I.s. 14 
Single marker movement is identified if a single marker has moved more than 2.5 mm 15 
(3 times the mean total observer error) with respect to its CT1 position. Multiple 16 
marker movement is defined as the movement of two or more markers by the same 17 
distance. A change was defined as being characteristic for a patient’s MV if observed 18 
in more than 50% of cases.   19 
 20 
2.2 Comparison methods 21 
2.2.1 Second order moment analysis 22 
The second order central moment of a distribution of N points is its variance and is 23 
given by: 24 
 8 
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The position of di is specified in each of the three spatial directions: left-right (LR), 4 
superior-inferior (SI) and anterior-posterior (AP), allowing µ2 to be determine in each 5 
direction (to limit the number of variables, cross-moments were not considered). Two 6 
methods of comparing volumes A and B were considered: firstly comparison of the 7 
whole volume and secondly pair-wise comparison of markers. 8 
 9 
For the first method the variance index, m, was defined: 10 
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where µ2(A)  and µ2(B)  are the variance in marker positions in A and B respectively. 12 
m was evaluated in each direction (LR, SI and AP). This is expected to be sensitive to 13 
changes in rotation and deformation. 14 
 15 
For the pair-wise comparison of the marker positions, by subtracting marker positions 16 
in volume B from those in volume A the movement of the markers, δi, was measured. 17 
If we replace d with δ in equations 1 and 2 we may calculate the variance in the 18 
marker movements, µ2(A-B) and define similarity index ∆m, to be: 19 
1)(2 +−=∆ BAm µ      (4) 20 
(where the addition of 1 is used to ensure ∆m is 1 if the volumes are identical). This 21 
pair-wise approach was adopted to detect changes in the position of a single marker 22 
 9 
between images of A and B as an indication of single marker migration. As with m 1 
this may be calculated in each spatial direction.  2 
 3 
2.2.2 Volume analysis 4 
MVs were calculated for all scans. We define the volume index (VI). For the two 5 
volumes V(A) and V(B) this is given by: 6 
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(as with eq. 4, the addition of 1 ensures identical volumes have an index of 1). VI is 8 
constructed to be sensitive to change in volume only.  9 
 10 
2.2.3 Jaccard Index 11 
The Jaccard Index (JI) is defined as the intersection divided by the union of two 12 
sample sets. For the volumes A and B:  13 
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JI measures the overlap of the two volumes and a JI of unity indicates that the two 15 
volumes are identical in size, shape, position and orientation (14) and will be less than 16 
unity if any of these parameters differ i.e. the ideal value of the JI is 1. JI was 17 
evaluated both before (JI1) and after (JI2) the CoM of the markers in volumes A and 18 
B were shifted to a common origin. JI1 measured the differences in volume overlap 19 
between CT and PI volumes without set-up correction. Values of JI1 of less then 1 20 
may be due to translational shifts and changes in size, shape and orientation whilst JI2 21 
measure changes in size, shape and orientation of the volumes only. Neither of these 22 
indices can be used to determine specific changes only to indicate that one of these 23 
changes has occurred.  24 
 10 
 1 
2.2.4 Minkowski Index 2 
The Minkowski Similarity Index (MI) measures the similarity in shape of two 3 
volumes (A and B) and is given by (11): 4 
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where Vm(A,B) is the Minkowski mixed volume for volumes A and B (12). Volumes 6 
A and B are corrected for any difference in position or orientation: volume B is 7 
rotated until it’s orientation matches that of A as closely as possible. MI is sensitive to 8 
differences in shape only and therefore can be used to distinguish between changes in 9 
shape and other changes that occur. If no shape change has occurred MI will be equal 10 
to 1.  11 
 12 
2.3 Model analysis 13 
The effects of stochastic variations in measured marker positions due to observer 14 
variability were modelled to: 15 
• calculate the resulting uncertainty in the volumes and similarity indices 16 
measured for the patient data and 17 
• evaluate confidence intervals to represent threshold values for each of the 18 
indices for each patient MV; we define no change as a value of similarity 19 
index that lies within the confidence 95% interval. 20 
 21 
For each patient MV, 10000 sample volumes were generated by adding total observer 22 
error to each marker position in the LR, SI and AP directions. Observer errors were 23 
generated by randomly sampling a normal distribution with standard deviation equal 24 
 11 
to the total observer error (10). Similarity indices were calculated for the 10000 new 1 
volumes.  The distribution of the index values was non-normal and therefore the 2 
distribution was transformed by evaluating the cubed root of the index values. The 3 
resulting 95% confidence limits of this distribution were then found. Confidence 4 
limits were transformed back to give the 95% C.I. for each similarity index.  5 
 6 
 7 
3. RESULTS  8 
3.1 Observer error 9 
The coefficients of repeatability (standard deviation × 1.96) in each direction are 10 
given in table 1 for both CT and PI for each observer (intra-observer) and all 11 
observers (inter-observer). The total coefficient of repeatability (CT+PI) is used to 12 
calculate error in the similarity indices evaluated for measured MVs.  13 
 14 
3.2  Patient MVs and volume changes during treatment   15 
The implanted markers did not define a regularly shaped MV as shown for patients 3 16 
and 6 in figures 3(a) and 3(b). For patient 3, the outer 4 markers describe the largest 17 
MV and therefore 2 markers lie completely inside the MV (c.f. fig 1c).  The 18 
MV(CT1) for patient 6 is an example of an MV which is formed from all six markers.  19 
It can be seen that the MV surface comprises a set of triangular faces, MVs can be 20 
described using the greatest width and length of the largest face and the distance of 21 
the marker furthest from this face.  The dimensions of the MV(CT1) and the number 22 
of markers implanted for each patient are given in table 2.   23 
 24 
Five types of change were observed: 25 
 12 
 1 
1. translation 2 
2. rotation  3 
3. volume change 4 
4. single marker movement  5 
5. multiple marker movement (two or more markers) 6 
 7 
The observed MV changes between CT1 and a) first day of treatment (PI first) and b) 8 
all MVs measured during treatment are summarised in table 2. Column 5 of table 2, 9 
gives changes observed between CT1 and PI first. The maximum measured values are 10 
given if rotation, marker movement or volume change are observed. Column 6 of 11 
table 2 gives changes for all the MVs measured during treatment. In column 6, values 12 
given are maximum values for all portal imaging and CT2 MVs.  Translations were 13 
observed in the majority of patient MVs. These were excluded from further analysis 14 
as they may be corrected using couch shift. 15 
 16 
Two patients (4 and 11) had no substantial change between CT1 and treatment, one 17 
patient (patient 6) had rotation only and the remaining patients all had some marker 18 
movement. MVs for patients 1 and 10 were almost planar with thicknesses of less 19 
than 1mm. 20 
 21 
Figure 4 gives MV as a function of time. 95% confidence intervals are shown as error 22 
bars for the MV measured for CT1 and CT2 (indicated using larger data points) and 23 
on the first and last PI days. With the exception of patient 9 who had a large MV, 24 
observer error produces large uncertainty in the measured volumes because of the 25 
 13 
relatively small volume of the MVs compared to the magnitude of the observer errors. 1 
There was significant (P < 0.05) change in volume size between CT1 (day 0) and the 2 
first day of treatment for patients 5, 8 and 9.  Patient 9’s MV reduced between CT and 3 
treatment by 47% and by a total of 65% by the end of treatment. This patient had a 4 
large specimen size (100g ) and large volume of seroma is visible in CT1 (this patient 5 
did not receive a second CT scan).  The MVs of patients 5 and 8 shrink in volume by 6 
the end of treatment by 60% and 30% respectively.   7 
 8 
Patient 2 had a very thin volume which shows a large fluctuation (to below 60% of 9 
CT1 on days 10, 21 and 38 (CT2)).  This was a result of the movement of the most 10 
superior marker in the SI direction by 2mm. This is shown in figure 6.   11 
 12 
3.3  Similarity indices for patient data 13 
Similarity indices have been calculated between MV(CT1) and treatment MVs for all 14 
patients. Values for the first PI, last day of PI and CT2 are given in figure 5. m and 15 
∆m) were calculated in all 3 spatial directions and only the spatial direction the 16 
greatest change is given. Patients are grouped by type of MV change.  We define a 17 
significant change in index value (i.e. significantly different from 1) if it lies outside 18 
the 95% C.I.. There is good agreement between CT2 and the last days of treatment, 19 
indicating no systematic difference between the two imaging methods. Table 3 gives 20 
the percentage of MVs with “true-results” for each of the patients, where “true-21 
results” are defined as correct prediction of a change or no change using the similarity 22 
index and “false-results” give an incorrect prediction. We now consider each of the 23 
indices in turn. 24 
 25 
 14 
Variance index, m 1 
m indicates marker movement and volume change. From figure 5 m indicates change 2 
for MV(PI first), MV(PI last) and MV(CT2) for all patients where this happens.  m 3 
gives false positive results for patient 11 (PI first) and false negative results for 4 
patients 2 (PI first, PI last and CT2) and 3 (PI first) both of which have single marker 5 
movement. m also gives false results for patients 8 and 10 (table 3).  In the case of 6 
patient 2 single marker movement has been identified (table 2) however, this marker 7 
lies within the MV and as a consequence, variance, shape and  volume do not change. 8 
For patient 3 the marker movement is in the direction of the largest dimension and the 9 
variance is not affected until one marker moves more than 5mm.  10 
 11 
Marker movement index, ∆m 12 
∆m should also indicate marker movement or volume change. This index indicates 13 
changes for all MVs shown in figure 5 with the exception of patient 6. False positive 14 
results are given for patients 2, 4, 6 and 11.  15 
Jaccard Index, JI1 and JI2 16 
The Jaccard index should indicate translation, deformation, volume change or 17 
rotation. All patients had true positive results for JI1. From figure 5 JI2 indicates 18 
change for MV(day1) for patient1, this is in agreement with observed rotation. JI2 19 
also correctly indicates no change for patients 4 and 11. False negatives were seen for 20 
patients 2, 3, 4, 6 and 8 (table 3). For patient 2 the single marker movement is inside 21 
the MV and hence does not change the volume. Hence this single marker movement 22 
was not detected. From the manual analysis patient 3 has a high incidence of multiple 23 
marker movement, which was not detected by JI2. This was also the case for 24 
 15 
MV(CT2) for patient 4.  For patient 6, rotations 6.2° and 6.3° were not detected.  For 1 
patient 8, single marker movement of 2.55mm was not detected for one MV only.  2 
 3 
Volume Index 4 
The volume index gives an incidence of true results of 100% for all patients.  5 
  6 
Minkowski Index, MI 7 
MI should indicate shape change only. For all patients except 2 and 3 MI gives an 8 
incidence of true results of 100%. False negative results for patient 2 occurred due to 9 
single marker movement inside the MV (as described above). Marker movement for 10 
patient 3 was also not detected by the Minkowski index because the shape does not 11 
change significantly.  12 
 13 
From the above analysis, a single index cannot distinguish between single marker 14 
movement and deformation. It has been seen that in some cases JI2 and the MI do not 15 
indicate marker movement where the MV shape does not change. However, these 16 
changes can be detected by ∆m.  17 
 18 
DISCUSSION 19 
Significant reduction in the size of the MV was observed for 3 patients. Other studies 20 
have measured reduction of the volume of excision cavity during breast radiotherapy 21 
for a larger proportion of patients. Using CT scanning, Jacobson et al. (3) found that 22 
of 20 patients, 16 had a greater than 20% decrease in excision cavity volume 4 to 5 23 
weeks into radiotherapy. Oh et al. (13) performed a similar analysis for 31 patients 24 
and found a mean reduction of 22.5% in the excision cavity volume. In both studies, 25 
 16 
excision cavities were defined using surgical clips, seroma and anatomical changes 1 
seen in the CT.  The mean marker volumes measured by Jacobson and Oh and in this 2 
study were 36.1cm3, 36.6cm3 and 3.12 cm3 respectively.  Median time between CT1 3 
and surgery was 88 days for this study and 60.9 for the Oh et al study (this data is not 4 
given by Jacobson et al.) and therefore shrinkage over this greater time period may 5 
account for the difference in volume.  However, due to the magnitude of the 6 
difference in volume (greater than a factor of 10) it is more likely that we have 7 
measured smaller volumes because we use only the marker positions to define volume 8 
and not seroma.  Furthermore, our surgeons  aim to obliterate the excision cavity to 9 
reduce seroma, thus we would expect the marker volumes to be small. Observer error 10 
in marker location using portal imaging was found to be less than 1mm, however the 11 
small dimensions of the MVs (2 - 60mm) means that this error creates large 12 
uncertainties in volume measurement and in the evaluation of the similarity indices.  13 
Therefore, in this study, uncertainties in measured marker volume are of the order of 14 
20% and so volume reduction for some patients may be undetectable. However, it is 15 
possible that the volumes used in this study do not tend to decrease by significant 16 
amounts as they are not defined using seroma, the volume of which we would expect 17 
to decrease with time post surgery.  In our study we use treatment PIs to measure the 18 
marker positions. Our treatment PIs had an acquisition time of 4.56s which is on the 19 
order of one breathing cycle and therefore any error in marker position measurement 20 
due to infraction motion is included in the observer error (markers were slightly 21 
blurred in the images). If shorter PI acquisition times are used it will be necessary to 22 
consider intrafraction motion in the estimation of measurement errors.  23 
Migration of surgical clips has previously been identified in two studies (7,8) however 24 
this feasibility study is the first to use markers that are sutured into the excision cavity 25 
 17 
wall. If we consider that the greatest amount of single marker movement detected was 1 
7mm for patient 2 and multiple marker movements of up to 13.3mm were also 2 
observed it is reasonable to assume that the single marker movement observed for 3 
patient 2 is due to anatomical changes and not due to marker migration. Large volume 4 
fluctuations observed for patient 2 were not a result of the 7mm marker movement 5 
(this marker was inside of the MV) but for the 2mm movement of the most superior. 6 
This marker moved back and forth in the SI direction during treatment. This motion 7 
may be due to slight changes in the patient’s arm position. 8 
 9 
In practice, the CTV will be derived from the MV, seroma and any anatomical 10 
changes evident on CT. However, the MV can be used in conjunction with the 11 
similarity indices to indicate anatomical changes. With the exception of m, similarity 12 
indices agreed well with the observed changes.  JI1 was found to be very sensitive to 13 
shifts in patient position. These shifts can also be measured using the CoM. In some 14 
cases, marker movements may not be indicated by JI2 or MI.  However, ∆m will be 15 
sensitive to these changes and alert to changes in the CoM. MI identifies shape change 16 
only.  These methods will not allow automatic distinction between single and multiple 17 
marker movement. To apply these techniques to adaptive radiotherapy, we suggest the 18 
verification protocol presented in figure 7. Interventions are shown by grey trapezoids 19 
and include repositioning, investigation into the need to re-plan a treatment and 20 
possible marker migration and/or a CoM changes.  After initial corrections for CoM 21 
shifts and rotations, VI is used to detect volume change, JI2 is used to detect changes 22 
in rotation or shape, MI detects shape change (if JI2 is positive and MI is negative 23 
then changes in JI2 must be due to rotation) and finally ∆m is used to detect marker 24 
movement and therefore possible migration.  25 
 18 
 1 
CONCLUSIONS 2 
Significant changes in size, shape and position occur to the fiducial marker defined 3 
volume during radiotherapy. We have shown that using a combination of similarity 4 
indices we can identify when changes in size and shape have occurred and devised a 5 
protocol to use these methods for adaptive radiotherapy. 6 
 7 
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14. Figures 1 
1. Schematic 2D diagram of the excision cavity boundary (dashed lines) and 6 2 
fiducial markers (circles) showing the variation in excision cavity volume 3 
contained within the MV. (a) and (b) show two possible MVs, (c) shows the 4 
MV containing the excision cavity volume which was chosen for this work. 5 
2. (a) Right anterior oblique portal image and (b) left anterior oblique portal 6 
image (1MU). The portal images were acquired at orthogonal angles.  7 
3. Schematic diagrams of implanted fiducial marker positions and MVs for (a) 8 
patient 3 and (b) patient 6. Rings represent the fiducial markers and the lines 9 
show the boundaries of the MVs. Shadow projections of the MVs are shown. 10 
4. Volume of patient MVs as a function of time. Error bars show 95% C.I.  for 11 
CT1(day 0),  MV(PI first), MV(PI last) and CT2 (large data points). 12 
5. Similarity index values for MVs on the first (PI first) and last day of treatment 13 
(PI last) and for CT2.  The ∆m bars correspond to the right hand axis. All other 14 
index values correspond to the left hand axis. Error bars indicate uncertainty in 15 
measurement due to observer error. Solid black boxes indicate index values 16 
that lie outside the threshold values (95% C.I.). 17 
6. (a) Left anterior oblique DRR (patient 2) from CT1 and portal images of  18 
markers acquired 8 (b) and 10 (c) days after CT1.  Implanted fiducial markers 19 
are circled. The change in the most superior marker is seen.  20 
7. Work flow diagram representing suggested protocol for use of similarity 21 
indices VI, JI2, MI and ∆m in an adaptive radiotherapy scheme.  22 
23 
 21 
Tables 1 
1. Observer Coefficients of repeatability for CT and PI measurements.  2 
2. Description of patient MV(CT1) and observed changes between CT1 and  3 
treatment and during treatment.  4 
3. Percentage of true results obtained using similarity indices for MVs. 100% 5 
indicates that all MV changes were correctly identified by the similarity index.  6 
 7 
 8 
